Sanil Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 27-06-2024
- Paid Up Capital ₹ 1.00 M
as on 27-06-2024
- Company Age 35 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.69 M
as on 27-06-2024
- Satisfied Charges ₹ 1.97 Cr
as on 27-06-2024
- Revenue -51.34%
(FY 2021)
- Profit -309.58%
(FY 2021)
- Ebitda -992.24%
(FY 2021)
- Net Worth -17.39%
(FY 2021)
- Total Assets 10.30%
(FY 2021)
About Sanil Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.69 M. The company has closed loans amounting to ₹1.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ishaan Rao, Nandan Rao, and Nilima Rao serve as directors at the Company.
- CIN/LLPIN
U24239KA1989PTC010426
- Company No.
010426
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sanil Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ishaan Rao  | Director | 24-Oct-2018 | Current |
| Nandan Rao | Director | 24-Oct-2018 | Current |
| Nilima Rao | Director | 30-Sep-1995 | Current |
Financial of Sanil Pharmaceuticals.
Sanil Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 51.34% decrease. The company also saw a substantial fall in profitability, with a 309.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanil Pharmaceuticals?
In 2021, Sanil Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Remidex Pharma Private LimitedActive 43 years 6 monthsIshaan Rao, Nandan Rao and 1 more are mutual person
Ishaan Labs Private LimitedActive 29 years 5 monthsIshaan Rao, Nandan Rao and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 31 Mar 2012 | ₹0.69 M | Open |
Canara Bank Creation Date: 23 Jul 2015 | ₹3.89 M | Satisfied |
Canara Bank Creation Date: 31 Mar 2012 | ₹0.69 M | Satisfied |
How Many Employees Work at Sanil Pharmaceuticals?
Sanil Pharmaceuticals has a workforce of 6 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanil Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanil Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
